Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review Research involving children that poses
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular endothelial growth factor (anti-VEGF), have
Why we exist Oncology research is moving quickly, and study teams face mounting complexity: novel modalities, new data tools, shifting
This white paper examines four KPIs most impacting timelines and budgets and offers strategies for effective communication and risk mitigation.
For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of client services at Advarra, Jani
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how
AI is becoming a routine part of how research proposals are prepared and reviewed, from drafting applications to supporting administrative
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
For nearly a decade, Francine Lopez has helped clinical research move from idea to impact. From her early days at
Client Experience Team Lead Jennifer DeZurik brings both professional and deeply personal connections to Advarra and the world of clinical
